Amgen Revenue Surges 10% in Q2

Amgen, a leading biotech company, reported a 10% increase in its second-quarter revenue to $10.1 billion.

The company's GAAP earnings per share rose 65% to $4.37, while its operating income increased to $3.5 billion and operating margin rose to 36.8%

Amgen's product sales grew by 9%, driven by volume growth, with 22 products delivering at least double-digit sales growth in the quarter.

The company generated $3.5 billion of free cash flow and ended June 30, 2026, with $14.0 billion in cash and cash equivalents.